Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).
About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.
A manufacturing problem in millions of Abbott glucose sensors has been tied to at least seven deaths and hundreds of injuries worldwide.
About 3 million ‘Freestyle Libre 3 and 3 plus are being recalled because they can give dangerous false readings. Suspect who rammed vehicle into Michigan synagogue is dead Trump's approval rating with ...
Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce falsely low glucose readings ...
Latin America's leading e-commerce and fintech platform, today announced fourth quarter and full year 2025 financial results. This quarter, Mercado Libre delivered net revenue and financial income of ...
WASHINGTON — Three U.S. freestyle ski competitors rose to the top of the podium Saturday during the mixed team aerials final, winning back-to-back gold for Team USA. The win sets a new record for the ...
WASHINGTON — Three U.S. freestyle ski competitors rose to the top of the podium Saturday during the mixed team aerials medal event. The Team USA trio of Connor Curran, Kaila Kuhn and Christopher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results